Suchergebnisse - "*Ritonavir"

PubPharm (275)

1

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Cao, B. | Wang, Y. | Lu, H. | +28

CommentIn: N Engl J Med. 2024 Apr 25;390(16):1533-1534. - PMID 38657253

2

Second-Line Switch to Dolutegravir for Treatment of HIV Infection

enthalten in: The New England journal of medicine | 2023

von Ombajo, L. | Penner, J. | Nkuranga, J. | +12

3

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older : a PK substudy of the SMILE trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Abdalla, S. | Compagnucci, A. | Zheng, Y. | +39

4

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA) : week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

enthalten in: The lancet. HIV | 2022

von Paton, N. | Musaazi, J. | Kityo, C. | +101

CommentIn: Lancet HIV. 2022 Jun;9(6):e368-e369. - PMID 35460602

5

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

6

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

7

Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia

enthalten in: International immunopharmacology | 2021

von Solaymani-Dodaran, M. | Ghanei, M. | Bagheri, M. | +41

CommentIn: Int Immunopharmacol. 2022 Jan;102:107693. - PMID 34217670

8

Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life

enthalten in: Scientific reports | 2021

von Nagot, N. | Singata-Madliki, M. | Cournil, A. | +16

9

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2020

von RECOVERY Collaborative Group | Horby, P. | Mafham, M. | +24

CommentIn: Lancet. 2020 Oct 24;396(10259):1310-1311. - PMID 33031761

10

Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome

enthalten in: The New England journal of medicine | 2020

von Arabi, Y. | Asiri, A. | Assiri, A. | +49

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]